Viral vectors for dendritic cell-based immunotherapy

被引：146

作者：

Jenne, L ^{[1
]}

Schuler, G ^{[1
]}

Steinkasserer, A ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany

来源：

TRENDS IN IMMUNOLOGY | 2001年 / 22卷 / 02期

关键词：

D O I：

10.1016/S1471-4906(00)01813-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Transduction of dendritic cells (DCs) by viral vectors genetically engineered to express tumor-associated antigens (TAAs) or cytokines can produce a high level of transgene expression and is an attractive approach for DC-based immunotherapy. Ex vivo transduction allows the control of DC quality, antigen quantity and site of DC reinjection. This review evaluates the viral vectors currently being developed for use in DC-based immunotherapy.

引用

页码：102 / 107

页数：6

共 49 条

[41] Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector [J].

Strobel, I ;

Krumbholz, M ;

Menke, A ;

Hoffmann, E ;

Dunbar, PR ;

Bender, A ;

Hobom, G ;

Steinkasserer, A ;

Schuler, G ;

Grassmann, R .

HUMAN GENE THERAPY, 2000, 11 (16) :2207-2218

[42] NONREPLICATING VACCINIA VECTOR EFFICIENTLY EXPRESSES RECOMBINANT GENES [J].

SUTTER, G ;

MOSS, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10847-10851

[43]

Szabolcs P, 1997, BLOOD, V90, P2160

[44] Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma [J].

Thurner, B ;

Haendle, I ;

Röder, C ;

Dieckmann, D ;

Keikavoussi, P ;

Jonuleit, H ;

Bender, A ;

Maczek, C ;

Schreiner, D ;

von den Driesch, P ;

Bröcker, EB ;

Steinman, RM ;

Enk, A ;

Kämpgen, E ;

Schuler, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1669-1678

[45] Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application [J].

Thurner, B ;

Röder, C ;

Dieckmann, D ;

Heuer, H ;

Kruse, M ;

Glaser, A ;

Keikavoussi, P ;

Kämpgen, E ;

Bender, A ;

Schuler, G .

JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 223 (01) :1-15

[46] Viral subversion of the immune system [J].

Tortorella, D ;

Gewurz, BE ;

Furman, MH ;

Schust, DJ ;

Ploegh, HL .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :861-926

[47] A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier [J].

Xiang, ZQ ;

Yang, YP ;

Wilson, JM ;

Ertl, HCJ .

VIROLOGY, 1996, 219 (01) :220-227

[48]

Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO

[49]

2-P

← 1 2 3 4 5 →